IN179169B - - Google Patents

Info

Publication number
IN179169B
IN179169B IN982MA1994A IN179169B IN 179169 B IN179169 B IN 179169B IN 982MA1994 A IN982MA1994 A IN 982MA1994A IN 179169 B IN179169 B IN 179169B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
David John Heal
Maria Isabel Fernandez
Bruce Jermemy Sargent
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Priority to IN1544MA1996 priority Critical patent/IN182801B/en
Publication of IN179169B publication Critical patent/IN179169B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN982MA1994 1993-10-13 1994-10-11 IN179169B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1544MA1996 IN182801B (sh) 1993-10-13 1996-09-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321162A GB9321162D0 (en) 1993-10-13 1993-10-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
IN179169B true IN179169B (sh) 1997-09-06

Family

ID=10743505

Family Applications (1)

Application Number Title Priority Date Filing Date
IN982MA1994 IN179169B (sh) 1993-10-13 1994-10-11

Country Status (31)

Country Link
US (1) US5753665A (sh)
EP (1) EP0723546B1 (sh)
JP (1) JPH09503771A (sh)
CN (1) CN1040537C (sh)
AT (1) ATE188966T1 (sh)
AU (1) AU679573B2 (sh)
BG (1) BG62405B1 (sh)
BR (1) BR9407812A (sh)
CA (1) CA2173857A1 (sh)
CZ (1) CZ106996A3 (sh)
DE (1) DE69422724T2 (sh)
DK (1) DK0723546T3 (sh)
ES (1) ES2142413T3 (sh)
FI (1) FI961630A0 (sh)
GB (1) GB9321162D0 (sh)
GR (1) GR3032480T3 (sh)
HU (1) HUT74580A (sh)
IL (1) IL111259A (sh)
IN (1) IN179169B (sh)
MY (1) MY112110A (sh)
NO (1) NO306509B1 (sh)
NZ (1) NZ274500A (sh)
PL (1) PL177920B1 (sh)
PT (1) PT723546E (sh)
RO (1) RO117020B1 (sh)
RU (1) RU2136684C1 (sh)
SK (1) SK282329B6 (sh)
TW (1) TW372237B (sh)
UA (1) UA42738C2 (sh)
WO (1) WO1995010521A1 (sh)
ZA (1) ZA947949B (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506382D0 (en) * 1995-03-29 1995-05-17 Boots Co Plc Pharmaceutical compositions
GB9507348D0 (en) * 1995-04-08 1995-05-31 Knoll Ag Therapeutic agents
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
WO1998004559A2 (en) * 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
GB9617727D0 (en) * 1996-08-23 1996-10-02 Knoll Ag Process
GB9626746D0 (en) * 1996-12-23 1997-02-12 Knoll Ag Process
DE19706337A1 (de) * 1997-02-19 1998-08-20 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Estern
DE19706336A1 (de) * 1997-02-19 1998-08-20 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Alkoholen
DE19707008A1 (de) * 1997-02-21 1998-08-27 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Alkoholen
JP2002527519A (ja) * 1998-10-16 2002-08-27 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体のリガンドとしてのピラゾロトリアジン誘導体
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations
GB9906130D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Compounds for use in therapy
GB9906124D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Therapeutic agent
GB9914743D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
MXPA02011913A (es) * 2000-06-30 2003-04-22 Wyeth Corp Triazolopirimidinas sustituidas como agentes anticancer.
CA2554696C (en) 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
CA2735549A1 (en) 2008-08-29 2010-03-04 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
US20120095025A1 (en) * 2009-04-01 2012-04-19 Neurosearch A/S SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
WO2010112486A1 (en) * 2009-04-01 2010-10-07 Neurosearch A/S SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
EP2438069A1 (en) 2009-04-01 2012-04-11 NeuroSearch A/S Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
CN113874377A (zh) 2019-05-13 2021-12-31 埃科莱布美国股份有限公司 作为铜腐蚀抑制剂的1,2,4-三唑并[1,5-a]嘧啶衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE46306B1 (en) * 1977-02-11 1983-05-04 Ici Ltd Safeguarded toxic chemical compositions containing an emetic
WO1989001478A1 (en) * 1987-08-07 1989-02-23 The Australian National University ARYLOXY- AND ARALKYLTHIO-IMIDAZO[1,2-b]PYRIDAZINES
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
DE69422724T2 (de) 2000-09-07
RU2136684C1 (ru) 1999-09-10
DE69422724D1 (de) 2000-02-24
FI961630A (fi) 1996-04-12
EP0723546B1 (en) 2000-01-19
PL177920B1 (pl) 2000-01-31
ATE188966T1 (de) 2000-02-15
PT723546E (pt) 2000-04-28
ZA947949B (en) 1996-01-23
EP0723546A1 (en) 1996-07-31
GB9321162D0 (en) 1993-12-01
TW372237B (en) 1999-10-21
PL313970A1 (en) 1996-08-05
MY112110A (en) 2001-04-30
CN1040537C (zh) 1998-11-04
CN1135754A (zh) 1996-11-13
GR3032480T3 (en) 2000-05-31
FI961630A0 (fi) 1996-04-12
US5753665A (en) 1998-05-19
RO117020B1 (ro) 2001-09-28
SK282329B6 (sk) 2002-01-07
UA42738C2 (uk) 2001-11-15
CA2173857A1 (en) 1995-04-20
AU7855494A (en) 1995-05-04
DK0723546T3 (da) 2000-05-01
AU679573B2 (en) 1997-07-03
BG100485A (bg) 1996-11-29
CZ106996A3 (en) 1996-09-11
NO961435D0 (no) 1996-04-11
SK43796A3 (en) 1996-10-02
NO961435L (no) 1996-06-10
NZ274500A (en) 1997-06-24
HUT74580A (en) 1997-01-28
ES2142413T3 (es) 2000-04-16
BR9407812A (pt) 1997-05-06
IL111259A (en) 1998-02-08
JPH09503771A (ja) 1997-04-15
HU9600959D0 (en) 1996-06-28
NO306509B1 (no) 1999-11-15
IL111259A0 (en) 1995-03-30
BG62405B1 (bg) 1999-10-29
WO1995010521A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
FR2706990B1 (sh)
FR2706816B1 (sh)
IN179169B (sh)
FR2708262B1 (sh)
DK0698306T3 (sh)
IN178217B (sh)
FR2706762B1 (sh)
FR2706800B1 (sh)
FR2704071B1 (sh)
FR2706842B1 (sh)
FR2707049B1 (sh)
FR2707016B1 (sh)
IN178078B (sh)
CU22254A3 (sh)
IN175199B (sh)
IN179219B (sh)
ECSMU930015U (sh)
IN188612B (sh)
IN182001B (sh)
IN181980B (sh)
IN181793B (sh)
IN181313B (sh)
IN181244B (sh)
IN180963B (sh)
IN181282B (sh)